PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
11-Nov-2024 The Rise of Elastography Imaging: A Multi-Billion Dollar Industry Acumen Research and Consulting
11-Nov-2024 Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers Gilead Sciences Ltd.
11-Nov-2024 InnoScot Health innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS Scotland InnoScot Health
11-Nov-2024 Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board Ebenbuild
10-Nov-2024 New GMP Training with Certificate Pharma Lessons
07-Nov-2024 Liebherr presents its new Heavy-Duty cooling solutions for laboratories and healthcare Liebherr
07-Nov-2024 NHSBSA publishes latest prescribing costs report NHSBSA
06-Nov-2024 Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences Quell Therapeutics
06-Nov-2024 England and Wales fertility rate falls to lowest on record. Is that by choice, asks expert? London Medical Laboratory
05-Nov-2024 Leading digital insights consultancy, Creation Healthcare, and largest online global physician community, G-Med, announce historic partnership enabling comparative analysis of online conversations of millions of HCPs worldwide Creation Healthcare
04-Nov-2024 New analysis uncovers significant decrease in mental health staffing during austerity University of East Anglia
01-Nov-2024 The Howard de Walden Estate invests £52m in new HealthTech development as part of healthcare evolution The Howard de Walden Estate
01-Nov-2024 Latest Innovation Scorecard for the NHS in England published by the NHSBSA The NHS Business Services Authority (NHSBSA)
31-Oct-2024 TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank TOPVISION Eye Specialist Berhad
29-Oct-2024 Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics Medidata
29-Oct-2024 TREMFYA® (Guselkumab) is the first IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease JOHNSON & JOHNSON
29-Oct-2024 ASTRAZENCA SECURES ACCELERATED NICE RECOMMENDATION FOR WAINZUA™▼(EPLONTERSEN) in ENGLAND AND WALES FOLLOWING MHRA LICENCE TO TREAT HEREDITARY TRANSTHYRETIN AMYLOIDOSIS IN ADULT PATIENTS WITH STAGE 1 OR 2 POLYNEUROPATHY AstraZeneca
28-Oct-2024 Almirall´s 2024 Immunoskin conference hosts leading experts in inflammatory skin conditions to advance science and treatment options Almirall
28-Oct-2024 UPM Biomedicals launches FibGel™ the world’s first injectable nanocellulose hydrogel for medical devices UPM Biomedicals
28-Oct-2024 Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis AstraZeneca